These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35141229)

  • 1. A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma.
    Ouyang W; Jiang Y; Bu S; Tang T; Huang L; Chen M; Tan Y; Ou Q; Mao L; Mai Y; Yao H; Yu Y; Lin X
    Front Cell Dev Biol; 2021; 9():758777. PubMed ID: 35141229
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma.
    Jiang Y; Ouyang W; Zhang C; Yu Y; Yao H
    Front Cell Dev Biol; 2021; 9():817085. PubMed ID: 35127727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma.
    Jia H; Tang WJ; Sun L; Wan C; Zhou Y; Shen WZ
    Front Genet; 2022; 13():1017866. PubMed ID: 36699466
    [No Abstract]   [Full Text] [Related]  

  • 4. Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures.
    Lu F; Gao J; Hou Y; Cao K; Xia Y; Chen Z; Yu H; Chang L; Li W
    Front Oncol; 2022; 12():876360. PubMed ID: 35785179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma.
    Li F; Song QZ; Zhang YF; Wang XR; Cao LM; Li N; Zhao LX; Zhang SX; Zhuang XF
    Front Genet; 2022; 13():1008416. PubMed ID: 36186418
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and clinical validation of a necroptosis-related gene signature for prediction of prognosis and tumor immunity in lung adenocarcinoma.
    Lei K; Tan B; Liang R; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M
    Am J Cancer Res; 2022; 12(11):5160-5182. PubMed ID: 36504901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratin gene signature expression drives epithelial-mesenchymal transition through enhanced TGF-β signaling pathway activation and correlates with adverse prognosis in lung adenocarcinoma.
    Li G; Guo J; Mou Y; Luo Q; Wang X; Xue W; Hou T; Zeng T; Yang Y
    Heliyon; 2024 Feb; 10(3):e24549. PubMed ID: 38322947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five glycosylation-related gene signatures predict the prognostic risks of lung adenocarcinoma.
    Liu XH; Yang YM; Zhang MM; Fu HY
    Gen Physiol Biophys; 2023 Nov; 42(6):479-493. PubMed ID: 37994425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma.
    Feng S; Huang C; Guo L; Wang H; Liu H
    Heliyon; 2022 Jan; 8(1):e08713. PubMed ID: 35036605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma.
    Zhao F; Wang Z; Li Z; Liu S; Li S
    Front Immunol; 2022; 13():980508. PubMed ID: 36275729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma.
    Lin T; Wang H; He X
    J Oncol; 2022; 2022():1827987. PubMed ID: 35966889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
    Tang Y; Jiang Y; Qing C; Wang J; Zeng Z
    Aging (Albany NY); 2020 Dec; 13(1):794-812. PubMed ID: 33340396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis.
    Chen S; Huang M; Zhang L; Huang Q; Wang Y; Liang Y
    Comput Struct Biotechnol J; 2024 Dec; 23():369-383. PubMed ID: 38226313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine Learning-Based Integration Develops a Macrophage-Related Index for Predicting Prognosis and Immunotherapy Response in Lung Adenocarcinoma.
    Li Z; Guo M; Lin W; Huang P
    Arch Med Res; 2023 Nov; 54(7):102897. PubMed ID: 37865004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Immune Implication and Prognostic Value of
    Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
    Front Oncol; 2021; 11():798425. PubMed ID: 35047409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Wang J; Zhan X
    Front Immunol; 2021; 12():752643. PubMed ID: 34887858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments.
    Wang C; Lu T; Xu R; Chang X; Luo S; Peng B; Wang J; Yao L; Wang K; Shen Z; Zhao J; Zhang L
    J Thorac Dis; 2022 Jun; 14(6):2131-2146. PubMed ID: 35813746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.